Skip to main content
. Author manuscript; available in PMC: 2015 Sep 24.
Published in final edited form as: Clin Immunol. 2013 Dec 17;150(2):184–191. doi: 10.1016/j.clim.2013.12.001

Figure 2.

Figure 2

Frequency of potential inhibitory markers on CD27CD21 B-cells from HCV-infected patients and controls. Frequency of positivity of A. CD305 (leukocyte-associated immunoglobulin-like receptor 1), B. Fc receptor-like protein 4 (FcRL4), C. CD22, and D. CD72. p-Values by the Wilcoxon tests within patient cohorts and across subsets are shown.